Retail & Wholesale » Retail | Kingworld Medicines Group Ltd.

Kingworld Medicines Group Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
79,758.30
61,248.90
63,304.70
104,040.70
96,083.30
83,361.90
Depreciation, Depletion & Amortization
1,916.60
2,169.70
25,996.80
26,949.60
28,146.90
32,496.70
Other Funds
14,811.30
83,055.40
-
-
48,992.40
31,563.30
Funds from Operations
44,481.90
43,021.60
43,745.40
96,683.10
94,347.90
84,295.20
Changes in Working Capital
105,323.20
55,535.10
75,492.70
111,124.80
17,010.30
20.10
Net Operating Cash Flow
60,841.30
12,513.60
119,238.10
14,441.70
77,337.50
84,315.40
Capital Expenditures
21,280.10
2,483.10
7,720.40
35,482.50
46,267.60
Sale of Fixed Assets & Businesses
15.10
2.50
-
-
77.30
Purchase/Sale of Investments
-
-
27,622.60
8,707.10
45,545.80
Net Investing Cash Flow
29,203.70
40,047.70
217,677.30
26,775.50
644.60
Cash Dividends Paid - Total
18,144.80
23,738.40
11,594.70
9,953.80
17,699.90
Issuance/Reduction of Debt, Net
48,573.60
296,694.60
75,386.60
167,827.00
4,350.60
Net Financing Cash Flow
45,240.20
189,900.80
86,981.40
157,873.20
71,042.80
Net Change in Cash
10,288.10
136,880.20
187,238.70
115,793.80
6,660.20
Free Cash Flow
82,121.50
14,996.60
111,517.80
49,924.20
31,069.90
Net Assets from Acquisitions
-
-
182,334.30
-
-
Other Sources
50,468.70
-
-
-
-
Exchange Rate Effect
3,314.50
459.40
1,818.20
862.30
12,310.40
Other Uses
-
37,567.10
-
-
-

About Kingworld Medicines Group

View Profile
Address
8th-9th Floor, Block A
Shenzhen Guangdong 518016
China
Employees -
Website http://www.kingworld.com.cn
Updated 07/08/2019
Kingworld Medicines Group Ltd. is an investment company, which engages in the distribution of imported branded pharmaceutical and healthcare products. It operates through the Distribution Sales of Pharmaceutical and Healthcare Products; and Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices. The Distribution Sales of Pharmaceutical and Healthcare Products segment distributes and sells branded imported pharmaceutical and healthcare products primarily in Hong Kong and the People's Republic of China.